125 related articles for article (PubMed ID: 29869881)
1. Preferential Cleavage of a Tripeptide Linkage by Enzymes on Renal Brush Border Membrane To Reduce Renal Radioactivity Levels of Radiolabeled Antibody Fragments.
Suzuki C; Uehara T; Kanazawa N; Wada S; Suzuki H; Arano Y
J Med Chem; 2018 Jun; 61(12):5257-5268. PubMed ID: 29869881
[TBL] [Abstract][Full Text] [Related]
2. Renal Handling of
Uehara T; Kanazawa N; Suzuki C; Mizuno Y; Suzuki H; Hanaoka H; Arano Y
Bioconjug Chem; 2020 Nov; 31(11):2618-2627. PubMed ID: 33085454
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
[TBL] [Abstract][Full Text] [Related]
4. Renal brush border enzyme-cleavable linkages for low renal radioactivity levels of radiolabeled antibody fragments.
Akizawa H; Imajima M; Hanaoka H; Uehara T; Satake S; Arano Y
Bioconjug Chem; 2013 Feb; 24(2):291-9. PubMed ID: 23330714
[TBL] [Abstract][Full Text] [Related]
5. In vitro system to estimate renal brush border enzyme-mediated cleavage of Peptide linkages for designing radiolabeled antibody fragments of low renal radioactivity levels.
Fujioka Y; Satake S; Uehara T; Mukai T; Akizawa H; Ogawa K; Saji H; Endo K; Arano Y
Bioconjug Chem; 2005; 16(6):1610-6. PubMed ID: 16287261
[TBL] [Abstract][Full Text] [Related]
6. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
[No Abstract] [Full Text] [Related]
7. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
[TBL] [Abstract][Full Text] [Related]
8. [Design of radiolabeled antibody fragments for tumor-selective radioactivity localization--brush border enzyme-sensitive bond to decrease renal accumulation of radioactivity].
Mukai T; Fujioka Y; Arano Y; Saji H
Yakugaku Zasshi; 2003 Aug; 123(8):647-52. PubMed ID: 12931660
[TBL] [Abstract][Full Text] [Related]
9. Reduction of the Renal Radioactivity of
Suzuki H; Araki M; Tatsugi K; Ichinohe K; Uehara T; Arano Y
J Med Chem; 2023 Jul; 66(13):8600-8613. PubMed ID: 37322876
[TBL] [Abstract][Full Text] [Related]
10. Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides.
Arano Y
Nucl Med Biol; 2021 Jan; 92():149-155. PubMed ID: 32169305
[TBL] [Abstract][Full Text] [Related]
11. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.
Li L; Olafsen T; Anderson AL; Wu A; Raubitschek AA; Shively JE
Bioconjug Chem; 2002; 13(5):985-95. PubMed ID: 12236780
[TBL] [Abstract][Full Text] [Related]
12. Strategies to reduce renal radioactivity levels of antibody fragments.
Arano Y
Q J Nucl Med; 1998 Dec; 42(4):262-70. PubMed ID: 9973841
[TBL] [Abstract][Full Text] [Related]
13. Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios.
Suzuki H; Kise S; Kaizuka Y; Watanabe R; Sugawa T; Furukawa T; Fujii H; Uehara T
ACS Omega; 2021 Aug; 6(33):21556-21562. PubMed ID: 34471758
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.
Ono M; Arano Y; Mukai T; Uehara T; Fujioka Y; Ogawa K; Namba S; Nakayama M; Saga T; Konishi J; Horiuchi K; Yokoyama A; Saji H
Nucl Med Biol; 2001 Feb; 28(2):155-64. PubMed ID: 11295426
[TBL] [Abstract][Full Text] [Related]
15. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
16. Renal metabolism of 3'-iodohippuryl N(epsilon)-maleoyl-L-lysine (HML)-conjugated Fab fragments.
Fujioka Y; Arano Y; Ono M; Uehara T; Ogawa K; Namba S; Saga T; Nakamoto Y; Mukai T; Konishi J; Saji H
Bioconjug Chem; 2001; 12(2):178-85. PubMed ID: 11312678
[TBL] [Abstract][Full Text] [Related]
17. Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate.
DePalatis LR; Frazier KA; Cheng RC; Kotite NJ
Cancer Res; 1995 Nov; 55(22):5288-95. PubMed ID: 7585590
[TBL] [Abstract][Full Text] [Related]
18. Single tumor cell uptake and dosimetry of technetium-99m Fab' or minute anti-CD22 in low-grade B-cell lymphoma.
Lindén O; Hindorf C; Tennvall J; Segrén S; Wingardh K; Strand SE
Cancer; 2002 Feb; 94(4 Suppl):1270-4. PubMed ID: 11877756
[TBL] [Abstract][Full Text] [Related]
19. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
Uehara T; Rokugawa T; Kinoshita M; Nemoto S; Fransisco Lazaro GG; Hanaoka H; Arano Y
Bioconjug Chem; 2014 Nov; 25(11):2038-45. PubMed ID: 25303645
[TBL] [Abstract][Full Text] [Related]
20. Distribution, elimination, and renal handling of (99m)technetium-Demogastrin 1.
Trejtnar F; Laznickova A; Laznicek M; Novy Z; Maina T; Nock BA; Behe M
Cancer Biother Radiopharm; 2012 Mar; 27(2):169-74. PubMed ID: 22409267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
